Figure C (Figure C)
Ivermectin Cream
Product Images NDC 71335-2946
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ivermectin (NDC 71335-2946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure D (Figure D)
Figures 1 And 2 (Figures 1 And 2)
This document appears to contain figures illustrating the success rates over time for two different creams: ivermectin cream and vehicle cream. The figures display the success rates in percentages at different time points, including baseline, week 2, week 4, week 8, and week 12 for Study 1.*
Figures 3 And 4 (Figures 3 And 4)
Figure A And B (Instructions)
Label (Lbl713352946)
The text provides information about a product containing ivermectin cream for topical use. The cream is labeled with 10 mg (1%) of ivermectin as the active ingredient. It is advised for use only topically and should not be taken orally, in the eyes, or intravaginally. The usual dosage is applying it to affected areas once daily. The package insert QR code can be scanned to access full prescribing information and a list of inactive ingredients. The cream should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Additionally, it is emphasized to keep the product out of reach of children.*
Formula (Structural Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
